National Stock Number
6505-01-285-0170
National Stock Number (NSN) 6505-01-285-0170, or NIIN 012850170, (iopamidol injection) was assigned November 9, 2021 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment.NIIN 012850170 was cancelled on March 2, 2017, with a cancelled status of "Item is Cancelled WITHOUT Replacement." There is no known replacement specified for this stock number. This NSN does not replace any other NSNs.
There are 4 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years.
There has been very little demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 01, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 50275. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505012850170 does not contain precious metals.
This NSN is associated to Schedule B 3006300000: opacifying preparations for x-ray examinations; diagnostic reageants designed to be administered to the patient. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on Jul 01, 2025.